Australian researchers have tested a miracle drug that they say “melts cancer cells away”, hailing it as a breakthrough for cancer patients worldwide.
The drug targets a specific protein that enables cancer to survive. During a Melbourne-based trial, researchers tested 116 patients over four years and discovered that the drug Venetoclax significantly reduces cancer blood cells.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
Elites Panic As Queen’s Death Threatens To Expose Pedophile Ring
WEF Anoint Charles ‘The Great Reset King’
WEF To Force Public To Wear ‘Brain Implants’ So the Elite Can Read Their Minds
Woody Harrelson Slams Big Pharma: 'The Last People You Should Trust With Your Health'
NASA Insider Confesses on Deathbed: I Filmed Fake Moon Landing in 1969
Disney’s ‘Little Demon’ Is Normalizing Satanism and Pedophilia for the Masses
Nostradamus Predicted 'Great Uprising' Against King Charles III
King Charles III Vows To Usher In ‘Great Reset’ Following Queen Elizabeth’s Death
Bill Gates’ Factory Breeding 30 Million Mosquitos Infected With ‘Infertility Bacteria’ Per Week
Positive results were seen in 79 percent of cases involving patients suffering from chronic lymphocytic leukemia. Some patients who had previously undergone treatment were left as good as new after agreeing to the new pill trials.
This is indeed historic news, as it marks the first trial of a medicine that is the result of three decades of research. “Here we are a bit under 30 years later in collaboration with WEHI and pharmaceutical companies here and in the US having proved that’s achievable,” head of haemotology, Professor John Seymour, told the Sydney Morning Herald.
“This is a completely new class of drugs and there is no other drug or medicine previously available that has had the ability to inhibit this BCL-2 protein,” he said, adding that the drug’s benefits also spread to other forms of cancer and leukemia than those tested.
Their results are published Thursday in the journal New England Journal of Medicine.
Success stories were heard from many chronically sick patients. One, Rodney Jacobs, 63, who owns a record shop in Melbourne, told the newspaper he was referred to the trial in 2012 after other therapies, including chemotherapy. Jacobs could not get a break.
“It was looking pretty bleak at that stage,” he told the paper. “The results have been nothing short of stunning… I’ve had little or no side effects and I slowly got myself back to work with my business and slowly but surely I have a relatively normal life.”
Roberts explained how the drug works, and it has to do with a specific protein called BCL-2, which helps cancer cells survive, making them simply “melt away.” It was first discovered in the 1980s, but scientists couldn’t find an inhibitor for it.
“I think this drug is going to be very significant and I think these results are significant in themselves because they show in real people exactly what the potential of this can be,” Roberts says. “Many of the people who achieved a complete remission are still in a complete remission more than a year later.”
Latest posts by Sean Adl-Tabatabai (see all)
- New Italian Leader Vows To Dismantle the ‘New World Order’ - September 27, 2022
- Rep. Adam Schiff Greets Ukraine Neo-Nazis in US Capitol: “They Are So Brave” - September 27, 2022
- CDC Finds ‘Lasting Post-Jab Heart Problems in Young Adults’ - September 27, 2022